ArticleArchivum immunologiae et therapiae experimentalis2023

Assessment of Motor Unit Potentials Duration as the Biomarker of DT-DEC01 Cell Therapy Efficacy in Duchenne Muscular Dystrophy Patients up to 12 Months After Systemic-Intraosseous Administration.

Adam Niezgoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.